Phibro Animal Health (NASDAQ: PAHC) reported Q1 EPS of $0.14, $0.11 worse than the analyst estimate of $0.25. Revenue for the quarter came in at $231.3 million versus the consensus estimate of $238.3 million.

GUIDANCE:

Phibro Animal Health sees FY2024 EPS of $1.04-$1.16, versus the consensus of $1.18. Phibro Animal Health sees FY2024 revenue of $0.98-1.02 billion, versus the consensus of $1.02 billion.

For earnings history and earnings-related data on Phibro Animal Health (PAHC) click here.